News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,378 Results
Type
Article (42890)
Company Profile (257)
Press Release (670231)
Multimedia
Podcasts (52)
Webinars (12)
Section
Business (207689)
Career Advice (2183)
Deals (36180)
Drug Delivery (100)
Drug Development (82362)
Employer Resources (178)
FDA (16452)
Job Trends (15148)
News (351508)
Policy (33262)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (8)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2678)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (50575)
ALS (89)
Alzheimer's disease (1397)
Antibody-drug conjugate (ADC) (126)
Approvals (16453)
Artificial intelligence (256)
Autoimmune disease (24)
Automation (16)
Bankruptcy (364)
Best Places to Work (11783)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (181)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (279)
Cancer (2273)
Cardiovascular disease (180)
Career advice (1822)
Career pathing (31)
CAR-T (154)
Cell therapy (432)
Cervical cancer (20)
Clinical research (66980)
Collaboration (840)
Compensation (524)
Complete response letters (20)
COVID-19 (2667)
CRISPR (42)
C-suite (242)
Cystic fibrosis (102)
Data (2206)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (279)
Diagnostics (6453)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (106)
Drug shortages (30)
Duchenne muscular dystrophy (95)
Earnings (87237)
Editorial (39)
Employer branding (22)
Employer resources (151)
Events (114379)
Executive appointments (733)
FDA (17705)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (757)
Gene editing (108)
Generative AI (21)
Gene therapy (310)
GLP-1 (741)
Government (4515)
Grass and pollen (5)
Guidances (59)
Healthcare (19206)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (120)
Indications (29)
Infectious disease (2814)
Inflammatory bowel disease (143)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (97)
Interviews (349)
IPO (16662)
IRA (44)
Job creations (3775)
Job search strategy (1550)
Kidney cancer (11)
Labor market (38)
Layoffs (474)
Leadership (19)
Legal (8099)
Liver cancer (76)
Lung cancer (322)
Lymphoma (154)
Machine learning (7)
Management (61)
Manufacturing (307)
MASH (68)
Medical device (13556)
Medtech (13561)
Mergers & acquisitions (20068)
Metabolic disorders (704)
Multiple sclerosis (82)
NASH (19)
Neurodegenerative disease (93)
Neuropsychiatric disorders (28)
Neuroscience (1936)
NextGen: Class of 2025 (6680)
Non-profit (4623)
Northern California (2673)
Now hiring (39)
Obesity (375)
Opinion (217)
Ovarian cancer (75)
Pain (86)
Pancreatic cancer (83)
Parkinson's disease (151)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (46)
People (58598)
Pharmaceutical (64)
Pharmacy benefit managers (20)
Phase I (20792)
Phase II (29485)
Phase III (22037)
Pipeline (1198)
Policy (144)
Postmarket research (2631)
Preclinical (8851)
Press Release (66)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (248)
Rare diseases (385)
Real estate (6066)
Recruiting (68)
Regulatory (22748)
Reports (47)
Research institute (2404)
Resumes & cover letters (368)
Rett syndrome (5)
RNA editing (5)
RSV (46)
Schizophrenia (70)
Series A (130)
Series B (84)
Service/supplier (12)
Sickle cell disease (53)
Southern California (2295)
Special edition (15)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3694)
State (2)
Stomach cancer (13)
Supply chain (71)
Tariffs (41)
The Weekly (31)
United States (23161)
Vaccines (710)
Venture capitalists (41)
Weight loss (248)
Women's health (35)
Worklife (18)
Date
Today (162)
Last 7 days (874)
Last 30 days (2637)
Last 365 days (33159)
2025 (10662)
2024 (35590)
2023 (40468)
2022 (51643)
2021 (56263)
2020 (54803)
2019 (47517)
2018 (35828)
2017 (32877)
2016 (32440)
2015 (38449)
2014 (32064)
2013 (27170)
2012 (29384)
2011 (30086)
2010 (28029)
Location
Africa (772)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (39342)
Australia (6508)
California (6113)
Canada (2011)
China (529)
Colorado (267)
Connecticut (274)
Delaware (146)
Europe (86106)
Florida (907)
Georgia (213)
Idaho (58)
Illinois (547)
India (26)
Indiana (313)
Iowa (11)
Japan (162)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (898)
Massachusetts (4576)
Michigan (222)
Minnesota (395)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1730)
New Mexico (29)
New York (1749)
North Carolina (976)
North Dakota (8)
Northern California (2673)
Ohio (204)
Oklahoma (14)
Oregon (34)
Pennsylvania (1377)
Puerto Rico (12)
Rhode Island (33)
South America (1154)
South Carolina (23)
South Dakota (1)
Southern California (2295)
Tennessee (103)
Texas (906)
Utah (180)
Virginia (146)
Washington D.C. (61)
Washington State (555)
West Virginia (3)
Wisconsin (53)
713,378 Results for "22nd century group inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th
April 7, 2025
·
1 min read
Press Releases
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 20, 2025
·
13 min read
Press Releases
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
April 28, 2025
·
5 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)
April 25, 2025
·
3 min read
Press Releases
Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024
·
1 min read
Press Releases
KRTL Holding Group Announces KRTL Biotech Inc. Signs MOU with Industria Químico Farmacéutica Sigma Corp. S.R.L. to Pursue Strategic International Merger
March 25, 2025
·
3 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), PRESENTING PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, AT THE AMERICAN SOCIETY OF CATARACT AND REFRACTIVE SURGERY ANNUAL MEETING
April 24, 2025
·
4 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Pharm Country
FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product
22nd Century Group, Inc. (Nasdaq: XXII), announced today that the U.S. Food and Drug Administration (FDA) has authorized the marketing of the Company’s VLN® King and VLN® Menthol King reduced nicotine content cigarettes as modified risk tobacco products (MRTPs).
December 23, 2021
·
9 min read
Biotech Beach
Biolase to Participate in Maxim Group’s 2023 Virtual Healthcare Conference Hosted by M-Vest on June 20th - 22nd
BIOLASE, Inc., the global leader in dental lasers, announced that President and Chief Executive Officer, John Beaver and Chief Financial Officer, Jennifer Bright, have been invited to participate in the 2023 Virtual Healthcare Conference, presented by Maxim Group LLC and hosted by M-Vest, on June 20th to 22nd.
June 14, 2023
·
2 min read
1 of 71,338
Next
